190 related articles for article (PubMed ID: 35941532)
21. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma.
Dunleavy K; Erdmann T; Lenz G
Cancer Treat Rev; 2018 Apr; 65():41-46. PubMed ID: 29549872
[TBL] [Abstract][Full Text] [Related]
22. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
23. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
Sármay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
[TBL] [Abstract][Full Text] [Related]
24. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.
Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L
Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493
[TBL] [Abstract][Full Text] [Related]
25. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
[TBL] [Abstract][Full Text] [Related]
26. MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.
Jablonska E; Gorniak P; Szydlowski M; Sewastianik T; Bialopiotrowicz E; Polak A; Warzocha K; Juszczynski P
Exp Hematol; 2017 Feb; 46():56-61.e1. PubMed ID: 27720936
[TBL] [Abstract][Full Text] [Related]
27. B-cell receptor signaling in diffuse large B-cell lymphoma.
Young RM; Shaffer AL; Phelan JD; Staudt LM
Semin Hematol; 2015 Apr; 52(2):77-85. PubMed ID: 25805587
[TBL] [Abstract][Full Text] [Related]
28. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
[TBL] [Abstract][Full Text] [Related]
29. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
[TBL] [Abstract][Full Text] [Related]
30. PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.
Yahiaoui A; Meadows SA; Sorensen RA; Cui ZH; Keegan KS; Brockett R; Chen G; Quéva C; Li L; Tannheimer SL
PLoS One; 2017; 12(2):e0171221. PubMed ID: 28178345
[TBL] [Abstract][Full Text] [Related]
31. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
32. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
Sasi BK; Martines C; Xerxa E; Porro F; Kalkan H; Fazio R; Turkalj S; Bojnik E; Pyrzynska B; Stachura J; Zerrouqi A; Bobrowicz M; Winiarska M; Priebe V; Bertoni F; Mansouri L; Rosenquist R; Efremov DG
Leukemia; 2019 Oct; 33(10):2416-2428. PubMed ID: 30872780
[TBL] [Abstract][Full Text] [Related]
34. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.
Li HL; Davis WW; Whiteman EL; Birnbaum MJ; Puré E
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6890-5. PubMed ID: 10359809
[TBL] [Abstract][Full Text] [Related]
35. Negative autoregulation of Src homology region 2-domain-containing phosphatase-1 in rat basophilic leukemia-2H3 cells.
Ozawa T; Nakata K; Mizuno K; Yakura H
Int Immunol; 2007 Sep; 19(9):1049-61. PubMed ID: 17675340
[TBL] [Abstract][Full Text] [Related]
36. BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma.
Yuan H; Zhu Y; Cheng Y; Hou J; Jin F; Li M; Jia W; Cheng Z; Xing H; Liu M; Han T
J Biol Chem; 2022 Nov; 298(11):102555. PubMed ID: 36183831
[TBL] [Abstract][Full Text] [Related]
37. SHP-1 deficiency in B-lineage cells is associated with heightened lyn protein expression and increased lyn kinase activity.
Yang W; Mckenna SD; Jiao H; Tabrizi M; Lynes MA; Shultz LD; Yi T
Exp Hematol; 1998 Nov; 26(12):1126-32. PubMed ID: 9808051
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
Ochi H; Watanabe T
Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
[TBL] [Abstract][Full Text] [Related]
39. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates.
Adachi T; Wienands J; Wakabayashi C; Yakura H; Reth M; Tsubata T
J Biol Chem; 2001 Jul; 276(28):26648-55. PubMed ID: 11356834
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]